naltrexone has been researched along with Brain Damage, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, W; Ding, Q; Gao, C; Sun, M; Sun, X; Yang, L; Yao, L; Yu, D; Zhao, X | 1 |
| Beaty, P; Corner, J; Read, A; Sommerville Ville, C | 1 |
| Panksepp, J; Sahley, TL | 1 |
3 other study(ies) available for naltrexone and Brain Damage, Chronic
| Article | Year |
|---|---|
Delta opioid receptor agonist BW373U86 attenuates post-resuscitation brain injury in a rat model of asphyxial cardiac arrest.
Topics: Animals; Asphyxia; Benzamides; Blotting, Western; Brain Damage, Chronic; Cardiopulmonary Resuscitation; CREB-Binding Protein; Disease Models, Animal; Heart Arrest; Immunoenzyme Techniques; Male; Naltrexone; Neuroprotective Agents; Piperazines; Rats, Sprague-Dawley | 2014 |
Reducing naltrexone-resistant hyperphagia using laser acupuncture to increase endogenous opiates.
Topics: Acupuncture Therapy; Adult; Brain Damage, Chronic; Dose-Response Relationship, Drug; Drug Administration Schedule; Feeding Behavior; Female; Humans; Hyperphagia; Lasers; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pica; Treatment Outcome; Ventromedial Hypothalamic Nucleus | 1996 |
Brain opioids and autism: an updated analysis of possible linkages.
Topics: Autistic Disorder; Brain; Brain Damage, Chronic; Child; Emotions; Endorphins; Humans; Language Development Disorders; Naloxone; Naltrexone; Receptors, Opioid; Serotonin; Social Behavior | 1987 |